Targeted protection through recombinant technology.

By using only pure outer surface protein A (OspA), RECOMBITEK Lyme provides efficacy without the potentially harmful flagellan protein.15 Plus, RECOMBITEK Lyme contains no chemical adjuvants, thus reducing the potential risk typically associated with adjuvants.

  • Recombinant subunit technology uses only a pure non-adjuvanted protein to stimulate immunity
  • In one study, shown to completely block transmission of Lyme disease spirochete18
  • Not a whole cell bacteria